JP Morgan Chase
AMYT

JP Morgan Chase’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

JP Morgan Chase’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,073
Closed -$45K – 7556
2023
Q1 		$45K Buy
3,073
+3,071
+153,550% +$43.4K ﹤0.01% 5738
2022
Q4 		$0 Hold
2
– – ﹤0.01% 7232
2022
Q3 		$0 Hold
2
– – ﹤0.01% 7049
2022
Q2 		$0 Hold
2
– – ﹤0.01% 7095
2022
Q1 		$0 Sell
2
-109
-98% -$984 ﹤0.01% 7197
2021
Q4 		$1K Buy
111
+45
+68% +$486 ﹤0.01% 6587
2021
Q3 		$1K Hold
66
– – ﹤0.01% 6425
2021
Q2 		$1K Hold
66
– – ﹤0.01% 6288
2021
Q1 		$1K Buy
+66
New +$922 ﹤0.01% 6004

JP Morgan Chase's AMYT Position: Q2 2023 in Review

JP Morgan Chase sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 3,073 shares — an estimated $45K sold.

JP Morgan Chase first reported a position in AMYT in Q1 2021 and held it in 9 quarters. The position peaked at $45K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • JP Morgan Chase reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Chase sold 3,073 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $45K.
  • JP Morgan Chase first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2021 and held it in 9 quarters.
  • JP Morgan Chase's Amryt Pharma plc American Depositary Shares position peaked at $45K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.